CAGRILINTIDE 5MG

This product is intended for research purposes only, and is not for human consumption. Cagrilintide is a research peptide increasing satiety and mimicking the amylin hormone to reduce appetite and support weight loss. It is being tested alone and in combination with the GLP-1 receptor agonist semaglutide (as CagriSema), a combination that has shown significant weight loss, improved glycemic control, and potential blood pressure reduction. While generally well-tolerated, common side effects include gastrointestinal issues such as nausea, constipation, and diarrhea.